KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Humana (HUM) over the last 17 years, with Q3 2025 value amounting to $5.5 billion.

  • Humana's Accounts Payables fell 669.48% to $5.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 billion, marking a year-over-year decrease of 669.48%. This contributed to the annual value of $5.3 billion for FY2024, which is 1994.22% down from last year.
  • Latest data reveals that Humana reported Accounts Payables of $5.5 billion as of Q3 2025, which was down 669.48% from $5.6 billion recorded in Q2 2025.
  • Over the past 5 years, Humana's Accounts Payables peaked at $8.1 billion during Q2 2023, and registered a low of $4.5 billion during Q4 2021.
  • For the 5-year period, Humana's Accounts Payables averaged around $6.0 billion, with its median value being $5.8 billion (2022).
  • Per our database at Business Quant, Humana's Accounts Payables skyrocketed by 4027.99% in 2023 and then tumbled by 2217.11% in 2024.
  • Humana's Accounts Payables (Quarter) stood at $4.5 billion in 2021, then increased by 16.17% to $5.2 billion in 2022, then rose by 25.41% to $6.6 billion in 2023, then fell by 19.94% to $5.3 billion in 2024, then increased by 4.94% to $5.5 billion in 2025.
  • Its last three reported values are $5.5 billion in Q3 2025, $5.6 billion for Q2 2025, and $5.4 billion during Q1 2025.